Normocalcemic with elevated post-operative parathormone in primary hyperpara-thyroidism: 9 case reports and literature review
Received date: 2020-07-20
Online published: 2021-06-16
目的: 对经外科治疗后出现甲状旁腺激素(parathyroid hormone, PTH)升高伴正常血钙(normocalcemic parathormone elevation,NPE) 的原发性甲状旁腺功能亢进症(primary hyperparathyroidism,PHPT)患者的临床特征进行分析,提高该病的诊治能力,完善PHPT患者的术后管理。方法: 选取2017年8月至2019年11月中日友好医院内分泌科诊断为PHPT且术后6个月内出现NPE的9例患者作为研究对象,回顾性分析其临床资料和转归,并进行相关文献总结。结果: 临床特点:9例患者中6例为中老年女性,3例为男性。除1例为无症状性PHPT,其余8例主要临床表现为骨痛、肾结石及恶心、乏力。实验室检查:就诊时均血钙升高[(3.33±0.48) mmol/L],血磷降低[0.76 (0.74,0.78) mmol/L],24 h尿钙升高[8.1 (7.8,12.0) mmol/24 h],全片段甲状旁腺激素(intact parathyroid hormone, iPTH)明显升高[(546.1±257.7) ng/L],维生素D缺乏[25羟维生素D3水平(21.0±5.7) nmol/L],骨源性碱性磷酸酶[7例41.3 (38.6,68.4) μg/L,2例>90 μg/L]及N端中段骨钙素(>71.4 μg/L)明显升高,2例患者存在肾功能异常。影像学检查:7例骨质疏松,3例患者肾脏超声见肾结石。所有患者甲状旁腺影像学检查均发现明确病灶, 其中2例为多发病灶,7例为单发病灶。治疗及转归:2例患者行甲状旁腺切除术治疗,其余患者予甲状旁腺微波热消融治疗;术后1个月患者均出现PTH升高[(255.0±101.4) ng/L],血钙正常,甲状旁腺超声未发现复发病灶。给予钙剂及维生素D联合治疗至术后6个月,PTH均显著下降,术后血钙水平始终正常。结论: PHPT术后发生NPE与术前PTH高水平、维生素D缺乏及肾功能受损可能相关,但并不意味着PHPT的复发或者存在残余病灶;术后充足的钙剂及维生素D的补充可能使患者获益;应规范对PHPT患者的术后随访,以预防和治疗术后NPE。
关键词: 原发性甲状旁腺功能亢进症; 甲状旁腺激素; 维生素D
谢玲玎 , 王娜 , 张金苹 , 王昕 , 陈晓平 , 张波 , 卜石 . 原发性甲状旁腺功能亢进症术后甲状旁腺激素升高9例并文献复习[J]. 北京大学学报(医学版), 2021 , 53(3) : 573 -579 . DOI: 10.19723/j.issn.1671-167X.2021.03.022
Objective: To summarize and analyze the clinical characteristics of primary hyperpara-thyroidism (PHPT) with normocalcemic parathormone elevation (NPE) after surgical treatment, so as to improve the therapeutic ability and standardized post-operative follow-up of PHPT patients. Methods: Nine patients who were diagnosed with PHPT in the Department of Endocrinology of China-Japan Friendship Hospital from August 2017 to November 2019 were selected as the subjects. They all developed NPE within 6 months after surgical treatment. The clinical features and outcomes were collected and analyzed retrospectively, in addition, the related literature was reviewed. Results: Clinical features: among the 9 patients, 6 were middle-aged and elderly females and 3 were male. The main clinical manifestations were bone pain, kidney stones, nausea and fatigue except for one case of asymptomatic PHPT. Pre-operative examination showed high serum calcium [(3.33±0.48) mmol/L], low serum phosphorus [0.76 (0.74,0.78) mmol/L], high 24-hour urinary calcium [8.1(7.8,12.0) mmol/24 h], obviously elevated intact PTH [(546.1±257.7) ng/L], vitamin D deficiency [25-hydroxyvitamin D3 (21.0±5.7) nmol/L]. Serum levels of bone alkaline phosphatase [7 patients 41.3(38.6,68.4) μg/L,2 patients >90 μg/L] and N-terminal midcourse osteocalcin (>71.4 μg/L) were significantly elevated. The estimated glomerular filtration rate decreased in 2 patients. Imaging examination: 7 patients had osteoporosis. Renal calculi were found in 3 patients by renal ultrasound. Imaging examination of parathyroid glands found definite lesions in all the patients, including 2 cases of multiple lesions and 7 cases of single lesions. Treatment and outcome: two patients underwent parathyroidectomy, while other patients were treated with microwave thermal ablation. PTH increased 1 month after therapy [(255.0±101.4) ng/L], and no recurrent lesions were found by parathyroid ultrasound. After combined treatment with cal-cium and vitamin D for six months, PTH decreased significantly and the level of serum calcium remained normal at anytime during the follow-up period. Conclusion: The occurrence of postoperative NPE may be related to the higher pre-operative PTH, vitamin D deficiency and lower creatinine clearance. However, NPE may not predict recurrent hyperthyroidism or incomplete parathyroidectomy. Adequate calcium and vitamin D supplementation after surgery seems to be beneficial for patients with NPE. Post-operative follow-up of PHPT patients should be standardized to prevent and treat post-operative NPE.
Key words: Primary hyperparathyroidism; Parathyroid hormone; Vitamin D
| [1] | Silverberg SJ, Clarke BL, Peacock M, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop[J]. J Clin Endocrinol Metab, 2014,99(10):3580-3594. |
| [2] | Sun B, Guo B, Wu B, et al. Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016[J]. Osteoporos Int, 2018,29(3):635-642. |
| [3] | Yao XA, Wei BJ, Jiang T, et al. The characteristics of clinical changes in primary hyperparathyroidism in Chinese patients[J]. J Bone Miner Metab, 2019,37(2):336-341. |
| [4] | 中华医学会骨质疏松和骨矿盐疾病分会, 中华医学会内分泌分会代谢性骨病学组. 原发性甲状旁腺功能亢进症诊疗指南[J]. 中华骨质疏松和骨矿盐疾病杂志, 2014,7(3):187-198. |
| [5] | Wei Y, Peng L, Li Y, et al. Clinical study on safety and efficacy of microwave ablation for primary hyperparathyroidism[J]. Korean J Radiol, 2020,21(5):572-581. |
| [6] | Fan BQ, He XW, Chen HH, et al. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study[J]. Eur Radiol, 2019,29(10):5607-5616. |
| [7] | Biskobing DM. Significance of elevated parathyroid hormone after parathyroidectomy[J]. Endocr Pract, 2010,16(1):112-117. |
| [8] | Goldfarb M, Gondek S, Irvin GL, 3rd, et al. Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years[J]. Surgery, 2011,150(6):1076-1084. |
| [9] | Carsello CB, Yen TW, Wang TS. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter?[J]. Surgery, 2012,152(4):575-581. |
| [10] | Beyer TD, Solorzano CC, Prinz RA, et al. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism[J]. Surgery, 2007,141(6):777-783. |
| [11] | Lang BH, Wong IY, Wong KP, et al. Eucalcemic parathyroid hormone elevation after parathyroidectomy for primary sporadic hyperparathyroidism: risk factors, trend, and outcome[J]. Ann Surg Oncol, 2012,19(2):584-590. |
| [12] | Duke WS, Kim AS, Waller JL, et al. Persistently elevated parathyroid hormone after successful parathyroid surgery[J]. Laryngoscope, 2017,127(7):1720-1723. |
| [13] | Caldwell M, Laux J, Clark M, et al. Persistently elevated PTH after parathyroidectomy at one year: experience in a tertiary referral center[J]. J Clin Endocrinol Metab, 2019,104(10):4473-4480. |
| [14] | Westerdahl J, Valdemarsson S, Lindblom P, et al. Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adenoma: sign of bone remineralization and decreased calcium absorption[J]. World J Surg, 2000,24(11):1323-1329. |
| [15] | Cao S, Hu Y, Zhao Y, et al. A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients[J]. Oncotarget, 2017,8(60):101158-101164. |
| [16] | Nordenstrom E, Westerdahl J, Isaksson A, et al. Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensiti-vity[J]. World J Surg, 2003,27(2):212-215. |
| [17] | Mittendorf EA, McHenry CR. Persistent parathyroid hormone elevation following curative parathyroidectomy for primary hyperparathyroidism[J]. Arch Otolaryngol Head Neck Surg, 2002,128(3):275-279. |
| [18] | Rianon N, Alex G, Callender G, et al. Preoperative serum osteocalcin may predict postoperative elevated parathyroid hormone in patients with primary hyperparathyroidism[J]. World J Surg, 2012,36(6):1320-1326. |
| [19] | Silverberg SJ, Gartenberg F, Jacobs TP, et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism[J]. J Clin Endocrinol Metab, 1995,80(3):729-734. |
| [20] | Ning L, Sippel R, Schaefer S, et al. What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism?[J]. Ann Surg, 2009,249(3):469-472. |
| [21] | Wang TS, Ostrower ST, Heller KS. Persistently elevated parathyroid hormone levels after parathyroid surgery[J]. Surgery, 2005,138(6):1130-1135. |
| [22] | Carty SE, Roberts MM, Virji MA, et al. Elevated serum parathormone level after “concise parathyroidectomy” for primary sporadic hyperparathyroidism[J]. Surgery, 2002,132(6):1086-1092. |
| [23] | Press D, Politz D, Lopez J, et al. The effect of vitamin D levels on postoperative calcium requirements, symptomatic hypocalcemia, and parathormone levels following parathyroidectomy for primary hyperparathyroidism[J]. Surgery, 2011,150(6):1061-1068. |
| [24] | Aberg V, Norenstedt S, Zedenius J, et al. Health-related quality of life after successful surgery for primary hyperparathyroidism: no additive effect from vitamin D supplementation: results of a double-blind randomized study[J]. Eur J Endocrinol, 2015,172(2):181-187. |
| [25] | Norenstedt S, Pernow Y, Zedenius J, et al. Vitamin D supplementation after parathyroidectomy: effect on bone mineral density: a randomized double-blind study[J]. J Bone Miner Res, 2014,29(4):960-967. |
| [26] | Rolighed L, Rejnmark L, Sikjaer T, et al. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial[J]. J Clin Endocrinol Metab, 2014,99(3):1072-1080. |
| [27] | Grubbs EG, Rafeeq S, Jimenez C, et al. Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?[J]. Surgery, 2008,144(6):852-858. |
| [28] | de la Plaza Llamas R, Ramia Angel JM, Arteaga Peralta V, et al. Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review[J]. Eur Arch Otorhinolaryngol, 2018,275(3):659-669. |
/
| 〈 |
|
〉 |